158 related articles for article (PubMed ID: 27494851)
1. Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.
Panza E; De Cicco P; Ercolano G; Armogida C; Scognamiglio G; Anniciello AM; Botti G; Cirino G; Ianaro A
Oncotarget; 2016 Aug; 7(35):57077-57085. PubMed ID: 27494851
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
4. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.
Panza E; Ercolano G; De Cicco P; Armogida C; Scognamiglio G; Botti G; Cirino G; Ianaro A
Biochem Pharmacol; 2018 Oct; 156():52-59. PubMed ID: 30098313
[TBL] [Abstract][Full Text] [Related]
6. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
7. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
[TBL] [Abstract][Full Text] [Related]
8. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.
Kim HS; Kim MJ; Kim EJ; Yang Y; Lee MS; Lim JS
Biochem Pharmacol; 2012 Feb; 83(3):385-94. PubMed ID: 22120676
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
Kuźbicki L; Sarnecka A; Chwirot BW
Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
[TBL] [Abstract][Full Text] [Related]
11. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas.
Soares CD; Borges CF; Sena-Filho M; Almeida OP; Stelini RF; Cintra ML; Graner E; Zecchin KG; Jorge J
Melanoma Res; 2017 Oct; 27(5):448-456. PubMed ID: 28604419
[TBL] [Abstract][Full Text] [Related]
14. Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Bastiaannet E; Hoekstra OS; Oyen WJ; Jager PL; Wobbes T; Hoekstra HJ
Ann Surg Oncol; 2006 Jul; 13(7):919-26. PubMed ID: 16788752
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
[TBL] [Abstract][Full Text] [Related]
16. COX-2 expression in malignant melanoma: a novel prognostic marker?
Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.
Zhou P; Qin J; Li Y; Li G; Wang Y; Zhang N; Chen P; Li C
J Exp Clin Cancer Res; 2017 Sep; 36(1):115. PubMed ID: 28865485
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
[TBL] [Abstract][Full Text] [Related]
19. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Zingg D; Debbache J; Schaefer SM; Tuncer E; Frommel SC; Cheng P; Arenas-Ramirez N; Haeusel J; Zhang Y; Bonalli M; McCabe MT; Creasy CL; Levesque MP; Boyman O; Santoro R; Shakhova O; Dummer R; Sommer L
Nat Commun; 2015 Jan; 6():6051. PubMed ID: 25609585
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
